Overview

  • Product nameSalmeterol xinafoate
  • Description
    Selective, long acting β2 adrenoceptor agonist
  • Biological descriptionSelective, long acting β2 adrenoceptor agonist. Inhibits release of histamine, leukotrienes, prostaglandin D2 and GM-CSF in concentration-dependent manner. Active in vitro and in vivo.
  • Purity> 96%

Properties

  • Chemical name4-Hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol xinafoate
  • Molecular weight603.75
  • Chemical structureChemical Structure
  • Molecular formulaC25H37NO4.C11H8O3
  • CAS Number94749-08-3
  • PubChem identifier56801
  • Storage instructionsStore at Room Temperature. Store under desiccating conditions. The product can be stored for up to 12 months.
  • Solubility overviewSoluble in ethanol to 25 mM and in DMSO to 100 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILESOCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2.O=C(O)c2ccc1ccccc1c2O
  • Source

    Synthetic

    References for Salmeterol xinafoate (ab120771)

    This product has been referenced in:
    • Fuso L  et al. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Curr Med Chem 20:1477-95 (2013). Read more (PubMed: 23409722) »
    • Akabane H  et al. Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. Allergol Int 55:387-93 (2006). Read more (PubMed: 17130681) »
    • Brogden RN & Faulds D Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Allergol Immunopathol (Madr) 20:72-84 (0). Read more (PubMed: 1359777) »

    See all 3 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120771.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"